3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Breast
1
Conditions
Breast Neoplasms
13
Motor Activity
6
Lymphedema
3
Breast Cancer Lymphedema
3
Fatigue
2
Depression
2
Ventricular Dysfunction, Left
1
Triple Negative Breast Neoplasms
1
Peripheral Nervous System Diseases
1
Pain
1
Neurotoxicity Syndromes
1
Neoplasms
1
Kinesiophobia
1
Heart Failure, Systolic
1
Chronic Pain
1
Body Weight Changes
1
Anxiety Disorders
1
Agnosia
1
Interventions
Paclitaxel
26
pembrolizumab
24
Docetaxel
20
Capecitabine
19
Fulvestrant
17
Trastuzumab
16
Anastrozole
15
Cyclophosphamide
14
Lapatinib
13
Letrozole
11
Carboplatin
11
Radiotherapy
10
Doxorubicin
10
palbociclib
9
Therapeutics
9
Nivolumab
9
Exercise
9
Gemcitabine
8
Cisplatin
8
Blood Specimen Collection
8
Tamoxifen
7
Bevacizumab
7
liposomal doxorubicin
6
exemestane
6
abemaciclib
6
Vinorelbine
6
Standard of Care
6
Fluorouracil
6
atezolizumab
5
Surveys and Questionnaires
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms
×
Exercise Therapy
×
Breast
×
Clear all
NCT04877860
2023-05-09
PaiNEd
Universidad de Granada
Phase NA
Unknown
72 enrolled